Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 01:03PM ET
5.60
Dollar change
0.00
Percentage change
0.00
%
Index- P/E37.81 EPS (ttm)0.15 Insider Own46.09% Shs Outstand57.48M Perf Week-3.45%
Market Cap321.83M Forward P/E13.49 EPS next Y0.41 Insider Trans0.00% Shs Float30.99M Perf Month-10.54%
Income8.28M PEG6.30 EPS next Q0.06 Inst Own12.73% Short Float0.15% Perf Quarter-9.97%
Sales142.52M P/S2.26 EPS this Y5.24% Inst Trans-2.76% Short Ratio1.84 Perf Half Y10.02%
Book/sh4.25 P/B1.32 EPS next Y84.44% ROA2.45% Short Interest0.05M Perf Year23.35%
Cash/sh0.97 P/C5.78 EPS next 5Y6.00% ROE3.94% 52W Range4.08 - 6.53 Perf YTD-8.50%
Dividend Est.- P/FCF- EPS past 5Y-21.07% ROI3.29% 52W High-14.23% Beta1.04
Dividend TTM- Quick Ratio1.64 Sales past 5Y5.73% Gross Margin38.94% 52W Low37.25% ATR (14)0.17
Dividend Ex-Date- Current Ratio3.43 EPS Y/Y TTM404.62% Oper. Margin7.71% RSI (14)40.64 Volatility2.51% 2.70%
Employees378 Debt/Eq0.04 Sales Y/Y TTM10.19% Profit Margin5.81% Recom1.00 Target Price12.00
Option/ShortYes / Yes LT Debt/Eq0.03 EPS Q/Q33.94% Payout0.00% Rel Volume0.41 Prev Close5.60
Sales Surprise-3.36% EPS Surprise93.20% Sales Q/Q-19.82% EarningsMar 06 BMO Avg Volume24.43K Price5.60
SMA20-5.16% SMA50-5.17% SMA2003.92% Trades Volume5,783 Change0.00%
Date Action Analyst Rating Change Price Target Change
Feb-02-18Initiated Chardan Capital Markets Buy $7
Mar-06-24 12:52PM
07:05AM
07:00AM
Feb-28-24 07:00AM
Dec-07-23 11:00AM
07:00AM Loading…
Dec-06-23 07:00AM
Nov-13-23 07:00AM
Nov-08-23 07:00AM
Oct-16-23 07:00AM
Oct-10-23 07:37AM
Aug-30-23 07:00AM
Aug-16-23 07:00AM
Aug-09-23 07:00AM
Jul-12-23 07:00AM
May-24-23 07:10AM
07:05AM Loading…
07:05AM
07:00AM
May-17-23 07:00AM
May-16-23 07:00AM
May-03-23 07:00AM
Mar-15-23 07:10AM
07:00AM
Mar-09-23 08:00AM
Jan-04-23 07:00AM
Dec-19-22 07:00AM
Dec-15-22 09:07AM
Dec-02-22 10:54AM
Nov-28-22 07:39AM
Nov-23-22 11:42AM
Nov-22-22 08:25AM
07:00AM Loading…
07:00AM
Nov-16-22 07:00AM
Nov-10-22 05:25PM
Nov-07-22 07:00AM
Oct-26-22 07:00AM
Oct-19-22 07:00AM
Oct-12-22 12:11PM
Sep-22-22 01:28PM
Sep-20-22 12:10PM
Sep-19-22 12:28PM
12:21PM
Sep-16-22 11:42AM
Sep-14-22 01:09PM
Sep-13-22 11:24AM
Sep-09-22 12:23PM
Aug-17-22 08:25AM
07:00AM
Aug-15-22 08:15AM
Aug-10-22 07:00AM
Jul-15-22 07:00AM
Jul-06-22 06:00AM
Jun-15-22 07:00AM
Jun-01-22 07:00AM
May-17-22 08:25AM
07:05AM
07:00AM
May-11-22 07:00AM
Mar-15-22 07:05AM
07:00AM
Mar-14-22 08:00AM
Mar-02-22 07:00AM
Nov-22-21 10:44AM
08:25AM
07:05AM
07:00AM
Nov-08-21 07:00AM
Oct-08-21 02:37AM
Oct-07-21 11:03PM
Aug-25-21 10:08AM
Aug-11-21 08:45AM
07:00AM
Aug-05-21 07:00AM
Aug-04-21 03:00PM
Jun-18-21 10:24AM
Jun-02-21 07:00AM
May-12-21 10:31AM
07:00AM
06:45AM
May-05-21 07:00AM
Apr-07-21 07:00AM
Mar-31-21 07:40AM
06:00AM
Mar-09-21 07:00AM
Mar-03-21 07:00AM
Feb-24-21 07:00AM
Feb-10-21 08:35AM
07:18AM
07:00AM
06:15AM
Feb-03-21 12:31PM
07:00AM
Feb-01-21 07:00AM
Jan-13-21 07:00AM
Jan-05-21 07:00AM
Dec-21-20 07:00AM
Dec-02-20 06:43PM
Nov-24-20 12:48PM
Nov-11-20 05:00PM
08:25AM
07:17AM
Kamada Ltd. is a biopharmaceutical company, which focuses on specialty plasma-derived therapeutic. It operates through the Proprietary Products and Distribution segments. The Proprietary Products segment covers the development, manufacture, and sale of plasma-derived protein therapeutics products. The Distribution segment covers the drug products in Israel, which are manufactured by third parties. The company was founded by David Tsur and Ralf Hahn on December 13, 1990 and is headquartered in Rehovot, Israel.